Concepedia

Publication | Open Access

Once-Weekly Exenatide in Youth With Type 2 Diabetes

DOIFull Paper Access

82

Citations

14

References

2022

Year

William V. Tamborlane, Raafat Bishai, David H. Geller, Naim Shehadeh, Dalia Al‐Abdulrazzaq, Evelina Mánica Vazquez, Eva Karoly, Tünde Troja, Orlando Doehring, Debra Carter,
Diabetes Care

Abstract

In youth with type 2 diabetes suboptimally controlled with current treatments, once-weekly exenatide reduced glycated hemoglobin at 24 weeks and was well tolerated.

References

YearCitations

Page 1